Cocrystal Pharma Will Ride A Wave Of Clinical Trial Success

Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, hepatitis C viruses, coronaviruses and noroviruses. They have a proprietary structural biology, enzymology and medicinal chemistry expertise enables Cocrystal Pharma to develop novel antiviral agents. These technologies and our market-focused approach to drug discovery are designed to effectively create small molecule therapeutics that are safe, effective and convenient to administer.

back

Cocrystal Pharma Will Ride A Wave Of Clinical Trial Success

Jun 21, 2020

bullish

general Analysis

[< 1 min Read]

Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, hepatitis C viruses, coronaviruses and noroviruses. They have a proprietary structural biology, enzymology and medicinal chemistry expertise enables Cocrystal Pharma to develop novel antiviral agents. These technologies and our market-focused approach to drug discovery are designed to effectively create small molecule therapeutics that are safe, effective and convenient to administer.
page loading card

COCP

Cocrystal Pharma, Inc.

0.42

0.02
5.57%

Return

-
Position Return %
0.00
Position Return
1.30
Price When Posted

Metrics

2.10
Target Price
8/ 10
Confidence
2-6 Months
Timeframe
catalyst icon
Earnings Release
catalyst icon
News
catalyst icon
SEC
Filing
catalyst icon
Sentiment
catalyst icon
Other Catalyst

Access the latest tools and discussion channels with an account

reddit-sentiment

Reddit Sentiment
Analysis

portfolio-balancer

Portfolio Balancer
with brokerages

sec-dashboard

SEC Dashboard
with NLP

aiodd-ad
next